Patient characteristics infected with Middle East respiratory syndrome coronavirus infection in a tertiary hospital

被引:33
作者
Alraddadi, Basem [1 ]
Bawareth, Noha [1 ]
Omar, Haneen [1 ]
Alsalmi, Hanadi [1 ]
Alshukairi, Abeer [1 ]
Qushmaq, Ismael [1 ]
Feteih, Maun [1 ]
Qutob, Mohammed [1 ]
Wali, Ghassan [1 ]
Khalid, Imran [1 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, POB 40047,MBC J102, Jeddah 21499, Saudi Arabia
关键词
Characteristics; Middle East respiratory syndrome coronavirus; patient; SAUDI-ARABIA; PNEUMONIA; OUTBREAK;
D O I
10.4103/1817-1737.180027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In April 2014, a surge in cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection was seen in Jeddah, Saudi Arabia. The aim of this study is to describe the demographic and clinical features, laboratory and radiological findings of MERS-CoV patients identified during this outbreak in a single tertiary hospital. Methods: All laboratory-confirmed MERS-CoV cases who presented to King Faisal Specialist Hospital from March 1, 2014, to May 30, 2014, were identified. Patients' charts were reviewed for demographic information, comorbidities, clinical presentations, and outcomes. Results: A total of 39 patients with confirmed MERS-CoV infection were identified. Twenty-one were male (54%), aged 40 19 years and included 3 (8%) pediatric patients (18-year-old). 16 (41%) patients were health care workers. Twenty-one (53%) patients were previously healthy whereas eighteen (47%) had at least one comorbidity. The predominant comorbidities included hypertension (31%), diabetes (26%), respiratory (23%), and renal disease (18%). Thirty patients (81%) were symptomatic at presentation, fever (69%) being the most common complaint. The overall mortality rate was 28%. In univariate analysis, older age, hypertension, and chronic kidney disease were associated with mortality. Conclusions: MERS-CoV presentation varies from asymptomatic infection to severe respiratory disease causing death. Future studies to identify the risk factors for worse outcome are needed.
引用
收藏
页码:128 / 131
页数:4
相关论文
共 13 条
  • [11] IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study
    Shalhoub, Sarah
    Farahat, Fayssal
    Al-Jiffri, Abdullah
    Simhairi, Raed
    Shamma, Omar
    Siddiqi, Nauman
    Mushtaq, Adnan
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (07) : 2129 - 2132
  • [12] WHO, 2019, Disease Outbreak News
  • [13] Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
    Zaki, Ali Moh
    van Boheemen, Sander
    Bestebroer, Theo M.
    Osterhaus, Albert D. M. E.
    Fouchier, Ron A. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (19) : 1814 - 1820